Follow The Filings

CDRE Cadre

Cadre earnings company data as of 9:57 AM ET 11/6

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 0.33 0.37 Beat +12.1%
Rev $190.5M $202.9M Beat +6.5%

Insider trades

Open-market buys and sales by CDRE's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CDRE insider trades
  • None no insider bought on the open market
  • $79.9M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Warren B Kanders CEO
    Sale
    $6.5M 200,000 shares at $32.61
    Traded Aug 24–25 Filed Aug 26
  2. Brad Williams President
    Sale
    $2.9M 88,742 shares at $33.24 58% of stake
    Traded Aug 17 Filed Aug 19
  3. Warren B Kanders CEO
    Sale
    $2.1M 75,000 shares at $27.57
    Traded Jun 18–22 Filed Jun 23
  4. Warren B Kanders CEO
    Sale
    $6.5M 225,000 shares at $29.06
    Traded Jun 15–17 Filed Jun 17
  5. Warren B Kanders CEO
    Sale
    $6.3M 200,000 shares at $31.67
    Traded Mar 20–23 Filed Mar 24
  6. Blaine Browers CFO
    Sale
    $895K 20,435 shares at $43.79 25% of stake
    Traded Dec 12, 2025 Filed Dec 16, 2025
  7. Brad Williams President
    Sale
    $1M 24,000 shares at $42.99 31% of stake
    Traded Dec 10, 2025 Filed Dec 12, 2025
  8. Warren B Kanders CEO
    Sale
    $52.4M 1,343,941 shares at $39.00
    Traded Nov 17, 2025 Filed Nov 19, 2025
  9. Brad Williams President
    Sale
    $1.2M 27,370 shares at $43.62 26% of stake
    Traded Nov 13, 2025 Filed Nov 17, 2025
  10. Brad Williams President
    Planned sale
    $178K 4,132 shares at $43.00 3.7% of stake
    Traded Oct 24, 2025 Filed Oct 28, 2025
  11. Brad Williams President
    Planned sale
    $165K 4,132 shares at $40.00 3.6% of stake
    Traded Oct 14, 2025 Filed Oct 16, 2025

Also filed in the last 12 months, not counted as buying or selling: 12 option exercises, 10 share withholdings for taxes, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
SCHEDULE 13D/A —
8-K/A 2.02,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 1.01,2.03,9.01
SCHEDULE 13D/A —
8-K 5.02,5.07
SCHEDULE 13G/A —
DEFA14A
8-K 2.02,9.01
10-Q
SCHEDULE 13G/A —
DEF 14A
8-K 2.02,9.01
10-K
SCHEDULE 13G —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf